User:Drmartadahiya

Dr. Marta Dahiya, a board-certified radiation oncologist, focuses the bulk of her work on breast and gynecological cancers. Committed to ensuring that all patients have access to the treatments that they need, Dr. Marta Dahiya maintains an in-depth knowledge of radiotherapy treatments for cancer. In late March of 2016, a research team at Main Line Health's Lakenau Institute for Medical Research in Pennsylvania announced the development of a new targeted approach for ovarian cancer. Most women with the disease undergo ovary removal followed by chemotherapy, which often eliminates the initial cancer but leaves the patient vulnerable to the grow.

Dr. Marta Dahiya has dedicated herself to increasing accessibility of breast cancer treatments. Dr. Marta Dahiya works to bring new treatments to developing nations, where the survival rates are lowest. Of the more than 500,000 women estimated to have lost their lives to breast cancer in 2011, approximately 58 percent likely lived in less developed countries. Although the number of diagnosed cases in these countries can be half that of nations in Western Europe, the prevalence of the disease is rising. Survival rates, however, remain below 40 percent, as compared to 80 percent or more in many high-income countries. The World Health Organization attributes the disparity in survival rates to the lack of early detection and proper diagnosis, which increases the prevalence of patients in the later stages of breast cancer. The organization also notes an insufficiency of treatment facilities equipped to deal with disease at multiple stages. Experts recommend an increase in access to multiple forms of treatment, including radiotherapy and chemotherapy.

The radiation oncologist is dedicated to helping underserved patients and works to ensure that all of her patients receive care regardless of insurance status or ability to pay. Dr. Marta Dahiya keeps abreast of new developments in radiation oncology through her membership in American Society of Radiation Oncology. The American Society of Radiation Oncology, or ASTRO, is an organization of more than 10,500 doctors who work together to fight cancer. Together, they treat over one million patients every year while participating in groundbreaking research in the fight against cancer.

ASTRO hosts its Annual Refresher Course each year, bringing members together to discuss current best practices in radiation oncology. The course offers a review of new developments, current clinical guidelines, and radiobiological principles related to treatment. With new treatments coming out on an almost daily basis, this conference helps professionals stay on the leading edge of medicine. The Refresher Course also looks forward into the coming years, previewing the technology of the future.

Radiation oncologist Dr. Marta Dahiya has practiced for more than a decade in San Antonio, Texas. A certified member of the American Board of Radiology, Dr. Marta Dahiya has completed additional specialization in gynecologic malignancies such as cervical cancer. Although cervical cancer rarely produces symptoms during the early stages of the disease, it is nevertheless important to recognize the signs and symptoms when they do occur. The most common symptoms of cervical cancer include vaginal bleeding, typically between periods or following sexual intercourse. Unusual vaginal discharge and pain during intercourse may also indicate cervical cancer. In the advanced stages of the disease, symptoms such as fatigue, weight loss, bone fractures, and leg pain can occur. Because cervical cancer is largely asymptomatic in the early stages, routine Pap screening is crucial in detecting abnormal cells in the cervix. In general, women are advised to begin receiving regular Pap tests at the age of 21. Gynecologists may also indicate tests for the high-risk strains of HPV, which can give rise to cervical cancers.

A board-certified radiation oncologist since 2005, Dr. Marta Dahiya currently practices at John Peter Smith Cancer Center in Fort Worth, Texas. Dr. Marta Dahiya treats patients with all types of cancer diagnoses, including breast cancer. While genetics play an important role in breast cancer development, lifestyle factors can also have an effect. Research has linked alcohol consumption to an increased risk of breast cancer, as well as several other types of cancers. Being obese or overweight, particularly after menopause, also increases breast cancer risk. From a prevention perspective, research suggests that moderate physical activity reduces breast cancer risk. Accordingto a study performed by the Women’s Health Initiative, women who engage in brisk walking for 1.25 to 2.5 hours per week enjoy an 18 percent decrease in breast cancer risk. Hormones also play a central role in breast cancer development. Women who take oral contraceptives have a slightly elevated breast cancer risk, which returns to normal after they stop taking them. In post-menopausalwomen, combined hormone therapy increases breast cancer risk, while estrogen therapy alone produces no considerable increase in risk